Standout Papers

Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degen... 2017 2026 2020 2023 357
  1. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration (2018)
    Frank G. Holz, Srinivas R. Sadda et al. JAMA Ophthalmology
  2. The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration (2017)
    Monika Fleckenstein, Paul Mitchell et al. Ophthalmology

Citation Impact

66 standout
Sub-graph 1 of 19

Citing Papers

Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go
2024 Standout
Age-Related Macular Degeneration
2024 Standout

Works of Christopher Brittain being referenced

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
2021
Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
2018
and 1 more

Author Peers

Author Ophthalmology RNMI Molecular Biology Last Decade Papers Cites
Christopher Brittain 1229 822 392 20 1.5k
Haeng Soon Park 3 10 118 14 326
Madison S. Cox 92 16 248
Charles A. McMellon 18 363
Ching‐Iuan Su 4 3 50 800
Roxana‐Mihaela Apetrei 1 170 25 567

All Works

Loading papers...

Rankless by CCL
2026